BAP31 deficiency reduced fatty acid oxidation and exacerbated liver steatosis in response to ethanol administration, primarily manifested by enhanced inflammatory responses, intensified ER stress, and depletion of hepatic glycogen reserves. This evidence concerns the gene BCAP31 and fatty liver disease.